Common prostate cancer treatment linked to later dementia, r
A new retrospective study of patient medical records suggests that men with prostate cancer who are treated with testosterone-lowering drugs are twice as likely to develop dementia within five years as prostate cancer patients whose testosterone levels are not tampered with.

The study, by researchers at the Stanford University School of Medicine and the University of Pennsylvania Perelman School of Medicine, also demonstrates emerging techniques for extracting biomedical data from ordinary patient medical records.

http://med.stanford.edu/news/all-news/2016/10/common-prostate-cancer-treatment-linked-to-later-dementia.html
Y●●●●●a P●●●●●●r and 1 others like this2 shares
Like
Comment
Share